Clinical Trial Update: Long-term Safety Trial with NVDX3 [Phase 1, Phase 2]

View source ↗

Summary

A long-term safety trial of NVDX3 in Phase 1/2 is currently recruiting to assess safety in distal radius fracture and degenerative lumbar spondylolisthesis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Degenerative Lumbar Spondylolisthesis
• Distal Radius Fracture

Drugs mentioned

• NVDX3

Snippet

Sponsor: Novadip Biosciences | Conditions: Distal Radius Fractures, Degenerative Lumbar Spondylolisthesis | Phase 1, Phase 2 | Status: RECRUITING